Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 26, 2010 MAIN DOCUMENT DESCRIPTION
4 Feb 26, 2010 MAIN DOCUMENT DESCRIPTION
4 Feb 26, 2010 MAIN DOCUMENT DESCRIPTION
10-K Feb 26, 2010 FORM 10-K
SC 13G Feb 16, 2010 DOC ONE
8-K Feb 11, 2010 FORM 8-K
4 Feb 9, 2010 MAIN DOCUMENT DESCRIPTION
8-K Feb 5, 2010 FORM 8-K
8-K Feb 2, 2010 FORM 8-K
8-K Jan 14, 2010 FORM 8-K
3 Dec 23, 2009 MAIN DOCUMENT DESCRIPTION
8-K Dec 22, 2009 FORM 8-K
8-K Dec 10, 2009 FORM 8-K
4 Dec 9, 2009 MAIN DOCUMENT DESCRIPTION
8-K Dec 1, 2009 FORM 8-K
4 Nov 13, 2009 MAIN DOCUMENT DESCRIPTION
10-Q Nov 9, 2009 FORM 10-Q
4 Oct 21, 2009 MAIN DOCUMENT DESCRIPTION
4 Oct 19, 2009 MAIN DOCUMENT DESCRIPTION
4 Oct 19, 2009 MAIN DOCUMENT DESCRIPTION
4 Oct 19, 2009 MAIN DOCUMENT DESCRIPTION
8-K/A Oct 15, 2009 FORM 8-K/A
8-K Oct 15, 2009 FORM 8-K
SC 13D/A Sep 25, 2009
8-K Sep 24, 2009 FORM 8-K
← Newer Page 28 of 38 · 935 filings Older →